Analysis of the relationship between antineoplastic drugs and suicide-related adverse events based on the food and drug administration adverse event reporting system database

Analysis of the relationship between antineoplastic drugs and suicide-related adverse events based on the food and drug administration adverse event reporting system database

Background: The potential association between new antineoplastic drugs and an increased risk of suicide-related adverse drug reactions remains unclear. This study aims to utilize the FAERS public database to analyze suicide-related adverse drug reactions associated with common antitumor drugs and to...

Full description

Saved in:

Bibliographic Details
Main Authors:	Nan Zhao, Huimin Wang, Huilin Xu, Xixian Tang, Dedong Cao
Format:	Article
Language:	English
Published:	SAGE Publishing 2024-12-01
Series:	SAGE Open Medicine
Online Access:	https://doi.org/10.1177/20503121241308686
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacovigilance study of famciclovir in the Food and Drug administration adverse event reporting system database
by: Runan Fang, et al.
Published: (2024-11-01)

Adverse drug reaction to tremelimumab and durvalumab in hepatocellular carcinoma patients: an analysis of the food and drug administration adverse event reporting system database
by: Wei Fan Sui, et al.
Published: (2025-08-01)

Risk Assessment of Linezolid-Associated Neurological Adverse Drug Reactions Based on the Food and Drug Administration Adverse Event Reporting System Database
by: Yin J, et al.
Published: (2025-05-01)

Adverse drug reactions to atezolizumab in combination with bevacizumab in hepatocellular carcinoma patients: an analysis of the food and drug administration adverse event reporting system database
by: Wanming He, et al.
Published: (2025-02-01)

Cardiovascular Adverse Events Associated with Prostate Cancer Treatment: A Disproportionality Analysis from the Food and Drug Administration Adverse Event Reporting System Database
by: Connor Frey
Published: (2024-11-01)

Safety assessment of ripretinib: a real-world adverse event analysis from the food and drug administration adverse event reporting system
by: Sentai Wang, et al.
Published: (2025-03-01)

Analysis of Adverse Events Associated With Dental Local Anaesthetics Using Food and Drug Administration Adverse Event Reporting System Data
by: Ferit Bayram, et al.
Published: (2025-06-01)

Real-world study of adverse events associated with triptan use in migraine treatment based on the U.S. Food and Drug Administration (FDA) adverse event reporting system (FAERS) database
by: Wen-Hui Liu, et al.
Published: (2024-11-01)

Reporting Adverse Drug Events in Drug Administration Process among Nursing Personnel
by: Katarzyna Kwiecień-Jaguś, et al.
Published: (2022-06-01)

Descriptive analysis of the national drug adverse events (AEs) database in Lebanon
by: Rita Karam, et al.
Published: (2025-12-01)

Safety Evaluation of the Combination with Dexrazoxane and Anthracyclines: A Disproportionality Analysis Based on the Food and Drug Administration Adverse Event Reporting System Database
by: Danyi Liu, et al.
Published: (2024-12-01)

Reporting of immune-related adverse events in US Food and Drug Administration approvals of immune checkpoint inhibitors
by: Shaili Tapiavala, et al.
Published: (2025-08-01)

An Exploratory Research to Evaluate the 30 Most Common Pulmonary Embolism Drugs in the Food and Drug Administration Adverse Event Reporting System
by: Hang Chen, et al.
Published: (2025-06-01)

Quality of the record of drug-related problems in a database for voluntary adverse event reporting
by: Maria Teresa Aznar-Saliente, et al.
Published: (2017-07-01)

Ophthalmic corticosteroids-related adverse events: the FDA adverse event reporting system (FAERS) database pharmacovigilance study
by: Chengzhi Liu, et al.
Published: (2024-12-01)

Risk of medication-induced lactic acidosis and hyperlactatemia: a pharmacovigilance study of the United States Food and Drug Administration’s Adverse Event Reporting System database
by: Houci Yang, et al.
Published: (2025-04-01)

Antibiotics-induced pulmonary embolism: A disproportionality analysis in Food and Drug Administration database of Adverse Event Reporting System using data mining algorithms
by: Pramod Kumar Adusumilli, et al.
Published: (2025-01-01)

Relationship between thromboembolic events and thrombopoietin receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System and the Japanese Adverse Drug Event Report
by: Zheng Wang, et al.
Published: (2025-08-01)

Adverse drug events associated with capecitabine: a real-world pharmacovigilance study based on the FAERS database
by: Rongqiang Liu, et al.
Published: (2024-12-01)

ICD-10 Codes to Identify Adverse Drug Events Associated with Antibiotics in Administrative Data
by: Hannah Lishman, et al.
Published: (2025-03-01)

Comparing drug combinations for graft-versus-host disease prophylaxis using the U.S. Food and Drug Administration Adverse Event Reporting System
by: Toru Ogura, et al.
Published: (2025-06-01)

Causes of drug-induced photosensitivity: an analysis using FDA adverse event reporting system database
by: Lele Ge, et al.
Published: (2025-05-01)

Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database
by: Xi-Feng Wang, et al.
Published: (2025-01-01)

Post-marketing safety concerns with pirfenidone and nintedanib: an analysis of individual case safety reports from the FDA adverse event reporting system database and the Japanese adverse drug event report databases
by: Tao Wang, et al.
Published: (2025-04-01)

A retrospective study of seasonal variation in sodium-glucose co-transporter 2 inhibitor-related adverse events using the Japanese adverse drug event report database
by: Kiyoka Matsumoto, et al.
Published: (2024-12-01)

A systematic review of adverse drug events associated with administration of common asthma medications in children.
by: James S Leung, et al.
Published: (2017-01-01)

Real-world pharmacovigilance analysis of drug-related cataracts using the FDA adverse event reporting system database
by: Xiang Li, et al.
Published: (2025-04-01)

Using multiple drug similarity networks to promote adverse drug event detection
by: Biswajit Padhi, et al.
Published: (2024-11-01)

Corrigendum: Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database
by: Xi-Feng Wang, et al.
Published: (2025-02-01)

Analysis and mining of Dupilumab adverse events based on FAERS database
by: Hui Gao, et al.
Published: (2025-03-01)

Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database
by: Chang-Zhu He, et al.
Published: (2025-03-01)

Exploring Human Misuse and Abuse of Veterinary Drugs: A Descriptive Pharmacovigilance Analysis Utilising the Food and Drug Administration’s Adverse Events Reporting System (FAERS)
by: Josie Dunn, et al.
Published: (2024-10-01)

Evaluating the association between migraine treatments and tinnitus: Insights from the US Food and Drug Administration adverse event reporting system.
by: Yun Kim, et al.
Published: (2025-01-01)

Abemaciclib-associated kidney injuries: A retrospective analysis of the United States Food and Drug Administration adverse events reporting system
by: Xiangchun Xu, et al.
Published: (2025-03-01)

Retrospective analysis of pembrolizumab-related adverse reactions and death outcomes based on the FAERS database
by: Huilin Xu, et al.
Published: (2025-05-01)

Factors associated with adverse events following immunization in Albanian children: An analysis of the national database of adverse events after immunization
by: Irsida Mehmeti, et al.
Published: (2019-03-01)

Evaluation of post-market adverse events of lubiprostone: a real-world adverse event analysis from the FAERS database
by: Qingqing Li, et al.
Published: (2025-05-01)

Excessive Hypocoagulation in Therapy with Warfarin within Polypharmacy: Using online database Multi-Drug Interaction Checker and Graphic “Time-Effect-Drug Administration” to Eliminate Adverse Drug Event (Case Report)
by: G. S. Krasnov, et al.
Published: (2018-11-01)

Adverse drug events associated with insulin glargine: a real-world pharmacovigilance study based on the FAERS database
by: Tongtong Wang, et al.
Published: (2025-04-01)

Drug-induced kidney stones: a real-world pharmacovigilance study using the FDA adverse event reporting system database
by: Pan Ding, et al.
Published: (2025-03-01)